Is Your Research Revenue In Danger?

Decentralized or site-less trials are becoming more and more common. According to ZS’s DCT database, site-less trials experienced a 77% compound annual growth rate between the second half of 2019 and 2020.¹ While this initial growth is due in part to the COVID-19 pandemic, the number of site-less trials is still going up. As reported by Clinical Trials Arena, we can expect a 28% increase in site-less and/or virtual clinical trials in 2022 compared to 2021.²